Registry for Severe ROP and Treatment on Visual Outcomes
Status: | Active, not recruiting |
---|---|
Conditions: | Ocular, Women's Studies |
Therapuetic Areas: | Ophthalmology, Reproductive |
Healthy: | No |
Age Range: | Any |
Updated: | 5/2/2018 |
Start Date: | May 2012 |
End Date: | January 2020 |
Study Registry for Severe Retinopathy and Treatment on Visual Outcomes of Premature Neonates
The purpose of this study is to determine what factors influence the visual outcomes of
infants with severe retinopathy of prematurity (ROP) and to monitor the outcomes.
infants with severe retinopathy of prematurity (ROP) and to monitor the outcomes.
Inclusion Criteria:
- Documentation of informed consent and authorization
- Inborn and those admitted within 7 days of birth
- Infant with a diagnosis of stage 2 ROP or higher
- Site ability to plan close ophthalmological follow-up due to significant and
persistent ROP
- Parents must agree to report outcomes following each ophthalmological visit and
overall outcomes for up to five (5) years of age
- Ability to obtain follow-up data on outcomes if the child is transferred to another
facility
- No known major congenital anomalies
Exclusion Criteria:
- ROP stage 1 or less
- Parents unwilling to participate in follow-up
- Major congenital anomalies
We found this trial at
2
sites
Memorial Hospital of South Bend Memorial Hospital of South Bend is a community-owned, not-for-profit corporation...
Click here to add this to my saved trials
Click here to add this to my saved trials